Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks

Documenti analoghi
Naturale o Cesareo, il parto che divide

Utilizzo e valutazione dell'offerta pubblica e privata di servizi radiotelevisivi nel 2017

Lo screening della preeclampsia nel I trimestre: un giudizio clinico. Paolo Accorsi Carpi

S. Bernasconi. Clinica Pediatrica. Università di Parma.

LDL come target per il controllo della dislipidemia HIV-correlata

Screening precoce della preeclampsia: un giudizio clinico. Carpi

Evacuazione chirurgica della cavità uterina: manovra ormai obsoleta? Dott.ssa Chiodo

Le demenze nella persona molto anziana

Andrea Ungar, MD, PhD, FESC

CONTROLLO BENESSERE FETALE E MODALITA DI PARTO NELLE GRAVIDANZE PMA

La gravidanza nella nefropatia diabetica

Mirta Mattina, psicologa Coordinatrice Gruppo di progetto Perinatalità Ordine Psicologi Lazio

Rischi della gravidanza in età avanzata. Dott.Gianluca Straface Responsabile UO Ostetricia Policlinico Abano Terme

FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA OSPEDALE I.R.C.C.S. OPERA DI SAN PIO DA PIETRELCINA SAN GIOVANNI ROTONDO Unità di Ricerca in Aterosclerosi

RHABDOMYOSARCOMA. IXa RABDOMIOSARCOMA 0-14 ANNI. Schede specifiche per tumore. I tumori in Italia Rapporto AIRTUM 2012 TUMORI INFANTILI

Varese 20 Settembre 2012 Terapia antitrombotica nelle pazienti sottoposte a PMA

Trombosi in sedi atipiche: il ruolo delle nuove mutazioni. Walter Ageno Dipartimento di Medicina Clinica Università dell Insubria Varese

ECCESSIVO INCREMENTO PONDERALE IN GRAVIDANZA: RISCHI MATERNO-FETALI

Diagnosi precoce: utopia o realtà?

Inibitori dell enzima DPP4 nell anziano

Cosa abbiamo imparato dagli studi SUP ed EGSYS-follow-up? Andrea Ungar. Syncope Unit

OSTEOSARCOMA. VIIIa OSTEOSARCOMA 0-14 ANNI. Schede specifiche per tumore. I tumori in Italia Rapporto AIRTUM 2012 TUMORI INFANTILI

Dott.ssa Anna Maria Colli U.O. di Cardiologia Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano

Università degli Studi di Napoli Federico II

In base all età gestazionale

UNIVERSITA DEGLI STUDI DI PADOVA

L Ostetricia e le Evidenze Presente e futuro per scelte efficaci 27 Settembre 2013

Sviluppo dei farmaci ipoglicemizzanti: metformina, acarbose, agonisti PPAR-γ

Effects of Exercise and Music on Psychological Well-Being and Exercise Performance

Chirurgia: miomi in riproduzione

SGA. Peso inferiore al 10º percentile per l epoca gestazionale Aumentata mortalità e morbosità perinatale. Lubchenco et al. 1963

LEUCEMIA MIELOIDE ACUTA

IRPPS Working Papers. Indagine su atteggiamenti e conoscenze di docenti e studenti nel corso del progetto:

Il ruolo della condizione psicosociale nel cambiamento degli stili di vita in pazienti con tumore del colon retto in follow up.

Cesarean Section in Italy C O L L. V I N C E N Z O G I A M B A N C O P A S T P R E S I D E N T S I G O

L c r c i r oco c nser e v r azi z on o e e d eg e li o voci c ti Dott.ssa a S il i v l ia i a Be B rn r ar a d r i

Corrado Amato U.O.S.D. di Angiologia Università di Palermo

Roma, 4 aprile Annali AMD 2006 Indicatori di qualità dell assistenza diabetologica in Italia Commenti al file-dati

Lo screening del diabete gestazionale in Toscana: uno studio di popolazione

Il timing del parto nelle patologie materne. Tiziana Frusca U.O. Ostetricia e Ginecologia Università degli Studi di Parma

Prevalenza e trattamento del dismetabolismo nel paziente anziano iperteso: evidenza del mancato controllo dei fattori di rischio cardiovascolare

Statistica per principianti

Gli Antidepressivi nella depressione maggiore. Trieste, 26 Febbraio 2009

Nuove Tecnologie. Automonitoraggio della glicemia oggi. Paolo Di Bartolo

Cardioversione a tutti i costi? Andrea Bettella Pronto Soccorso e Medicina d Urgenza Ospedale S. Antonio - Padova

La terapia antipertensiva ottimale nel paziente anziano: quando trattare e con quali obiettivi pressori Andrea Ungar, MD, PhD, FESC

Studio PPP (Progetto Prevenzione Primaria)

Dr.ssa A8alla El Halabieh Nadia

Confondenti e modificatori d effetto

Lesioni ghiandolari: il punto di vista molecolare. Giovanni Negri, Bolzano

Criteri di appropriatezza diagnosticoterapeutica RADIOTERAPIA. prof Giampaolo Biti Università di Firenze

Vaccinazioni antinfluenzale e outcome di salute: l esperienza di ASL Milano 1. Rho 3 ottobre 2015

Le differenti manifestazioni cliniche della Sindrome di Tourette negli adulti

RISK OF RESPIRATORY MORBIDITY AND MODE OF DELIVERY IN LATE PRETERM INFANTS

Germano Bettoncelli Roma 17 Novembre 2010

Novel ultrasound parameters to predict the response to induction of labor in postdate pregnancy

Filippo Caraci & Filippo Drago

POLIFARMACOTERAPIA NELL ANZIANO IN FVG: LETTURA CRITICA E PROPOSTE

Il neonato late preterm

Il geriatra legge le nuove linee guida ESH Andrea Ungar, MD, PhD, FESC

FACOLTÀ DI MEDICINA VETERINARIA

Quanto la selezione delle pazienti e la scelta dell endpoint primario possono influenzare i risultati? Lo studio CEREBEL

I CAMBIAMENTI PROTOTESTO-METATESTO, UN MODELLO CON ESEMPI BASATI SULLA TRADUZIONE DELLA BIBBIA (ITALIAN EDITION) BY BRUNO OSIMO

NASCERE SICURI IL PERCORSO NASCITA. Roma: Commissione Sanità Senato 5 Maggio Giulio Bevilacqua UNIVERSITY OF PARMA - ITALY

Comorbilità in gravidanza : Ipertensione. Vito Borzì Consulente Internista/Diabetologo

SCAI 2015 FELLOWS COURSE 6-9 DECEMBER PCI Left Main and Multi-vessel. Antonio Colombo

Gravidanza fisiologica ed ecografia del III trimestre pro e contro: Il parere dell ecografista.

Combinazioni serie HL-MHL + MHL. Sono disponibili varie combinazioni tra e riduttori coassiali serie MHL (2 stadio).

RIPOSO a LETTO in caso di contrazioni?

Monitoraggio clinico ed ecografico Chi fa cosa?

Jennifer Foglietta Oncologia medica- Perugia

Aspetti demografici ed epidemiologici dello scompenso cardiaco in Campania

Outcome delle gravidanze e dei nati da PMA: un update

Ordine dei Medici di Parma 23 settembre 2014

La restrizione della crescita intrauterina. Gianluigi Pilu Clinica Ostetrica e Ginecologica Università degli Studi di Bologna

19-20 Novembre 2014, Pisa Scuola Medica della Facoltà di Medicina. Co.Me.Lab 2014

DALLA SANITA D INIZIATIVA ALLA GESTIONE DELLE CRONICITA IN DEA

Variabilitàstagionale nell insorgenza della malattia peptica e dell utilizzo dei PPI: esiste una correlazione? Massimo Gallerani, Roberto Manfredini

Le esigenze cliniche del paziente oncologico in terapia

Il manuale WHO 2010 per l esame del liquido seminale: luci e ombre Bologna, 29 Gennaio M Cristina Meriggiola

A. Sciusco, P. Raimondo, C. Garzillo, A. Decapraris, L. Mirabella, G. Cinnella e M. Dambrosio

Auscultazione intermittente Vs CTG continuo

Valutazione delle evidenze: studio IBIS II

LE LINEE GUIDA: UTILIZZO RAZIONALE DELL ESPERIENZA ALTRUI

Follow-up e programmi di screening: Raccomandazioni europee e questioni aperte. Carlo Senore

Ridurre-eliminare la contenzione Ermellina Zanetti (Brescia) E.Zanetti GRG Brescia 1

Vaccinazioni ed emofilia si/no

La questione dei Multiple Comparisons

AVERE 30 ANNI E VIVERE CON LA MAMMA BIBLIOTECA BIETTI ITALIAN EDITION

Supplementazione orale nella prevenzione e nel trattamento della malnutrizione Alessandro Laviano

Esiti attesi dalla adozione di raccomandazioni su diabete

L OSTETRICIA E LE EVIDENZE 2015: PRESENTE E FUTURO PER SCELTE EFFICACI CON UNO SGUARDO ALLA GINECOLOGIA

Asimmetria nella percezione vocalica di L1: uno studio di sintesi articolatoria. KARYPIDIS, COSTAGLIOLA & GUGLIELMI, AISV 2005

Eterogeneità delle evidenze. Ivan Moschetti

Probability Distributions T O P I C # 1

Il Management delle Sindromi Coronarie Acute oggi Il paziente anziano e con IRC grave

Valutazione del Sistema informativo e delle fonti informative

Conservazione di ovociti in giovane età

I principali bias. bias:

Transcript:

Giorn. It. Ost. Gin. Vol. XXXV - n. 6 Novembre-Dicembre 2013 Department of Gyno-Obstetrics and Urologic Science, Sapienza University of Rome, Rome, Italy clinical case Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks M.G. DE STEFANO, E. ROSATO, E. MARCOCCIA, M.C. SCHIAVI, I. ZANNINI, O. CAPRI, P. GALOPPI, G. PERRONE SUMMARY: Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks. M.G. DE STEFANO, E. ROSATO, E. MARCOCCIA, M.C. SCHIAVI, I. ZANNINI, O. CAPRI, P. GALOPPI, G. PERRONE Aim of the study. The aim of our study is to evaluate the pregnancy complications, mode of delivery and neonatal outcome in women of advanced reproductive age ( 40 years) and very advanced reproductive age ( 45 years). Methods and materials. We selected 343 patients aged 40 years who subsequently gave birth at the Department of Obstetrics- Gynecology at the Policlinico Umberto I in Rome, between 2010 and 2011. We selected a control group of 527 patients aged between 25 and 35 who gave birth in the same period. After excluding twin pregnancies and intrauterine deaths, the study sample is made up of 312 patients, subdivided into two subgroups according to age: 40-44 years (group A: 274 patients) and age 45 years (group B: 38 patients), while the control group includes 510 patients. For each group we evaluated the pregnancy outcomes (chronic maternal diseases, gestational maternal diseases, obstetric complications), delivery (mode of delivery, gestational age at birth) and neonatal outcome (birth weight and Apgar). Obstetric history (parity and previous cesarean section), mode of onset of pregnancy (spontaneous or assisted reproductive technology) and duration of the hospital stay were reported. Results. We found in women over 40 compared to the control group a significant increase in the frequency of both chronic and gestational maternal diseases: diabetes mellitus (2.6% vs 0.4%), chronic hypertension (6.1% vs 2%), gestational diabetes (9% vs 2.5%), gestational hypertension (8.7% vs 2%); and of obstetric complications: oligohydramnios (7.4% vs 3.7%), intrauterine growth restricion-iugr (6.7% vs 2.5 %); an increase of cesarean section (70.2% vs 48.2 %) and an increased risk of neonatal complications such as prematurity (20.8% vs 7.5%), low birth weight (17.3% vs 10.6%) and Apgar score less than 7 at the first minute (7.4% vs 1.6%) were evidenced in the study group. We found no significant differences in the frequency of preeclampsia, placental disorders (placenta previa, placental abruption), instrumental delivery. RIASSUNTO: Gravidanza in età riproduttiva avanzata ( 40 anni) e molto avanzata ( 45 anni): complicanze materne e fetali. M.G. DE STEFANO, E. ROSATO, E. MARCOCCIA, M.C. SCHIAVI, I. ZANNINI, O. CAPRI, P. GALOPPI, G. PERRONE Obiettivo. L obiettivo del nostro studio è valutare l andamento della gravidanza, la modalità del parto e l outcome neonatale in donne in età riproduttiva avanzata ( 40 anni) e molto avanzata ( 45 anni). Materiali e metodi. Abbiamo selezionato 343 pazienti di età 40 anni che hanno successivamente partorito presso il Dipartimento di Scienze Ostetriche-Ginecologiche del Policlinico Umberto I di Roma, dal 2010 al 2011. Abbiamo poi selezionato un gruppo di controllo costituito da 527 pazienti di età compresa fra 25 e 35 anni che hanno partorito nello stesso periodo. Dopo aver escluso le gravidanze gemellari e le morti intrauterine, il campione di studio risulta costituito da 312 pazienti, a sua volta suddiviso in due sottogruppi in base all età: 40-44 anni (gruppo A: 274 pazienti) e di età 45 anni (gruppo B: 38 pazienti), mentre il gruppo di controllo comprende 510 pazienti. Per ciascun gruppo abbiamo valutato l andamento della gravidanza (patologie materne croniche, patologie materne gestazionali, complicanze ostetriche), il parto (modalità del parto, epoca gestazionale al parto) e l outcome neonatale (peso alla nascita e Apgar). Sono stati inoltre descritti: anamnesi ostetrica (parità e pregressi TC), modalità di insorgenza della gravidanza (spontanea o tecniche di fecondazione assistita) e durata della degenza. Risultati. Abbiamo riscontrato nelle donne over 40, rispetto al gruppo di controllo, un aumento significativo di frequenza di patologie materne sia croniche sia gestazionali, quali diabete mellito (2,6% vs 0,4%), ipertensione cronica (6,1% vs 2%), diabete gestazionale (9% vs 2,5%), ipertensione gestazionale (8,7% vs 2%); di complicanze ostetriche quali oligoamnios (7,4% vs 3,7%) e ritardo di crescita intrauterino-iugr (6,7% vs 2,5%); un aumentato ricorso al taglio cesareo (70,2% vs 48,2%) e un aumentato rischio di complicanze neonatali quali prematurità (20,8% vs 7,5%), basso peso alla nascita (17,3% vs 10,6%) e Apgar inferiore a 7 al primo minuto (7,4% vs 1,6%). Non abbiamo riscontrato differenze significative nella frequenza di preeclampsia, di disordini placentari (placenta previa e DI- Copyright 2014, CIC Edizioni Internazionali, Roma 740

Introduction Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks Considering only the group over 40, the comparison between group A (40-44 years) and group B ( 45 years) showed a significantly increased frequency of preeclampsia (1.5% vs 13.2%), gestational hypertension (5.8% vs 28.9%), cesarean section (67.2% vs 92.1%), low birth weight (15% vs 34.2%), prematurity (19.3% vs 31.6%) and Apgar score less than 7 at the first minute (5.8% vs 18.4%) in the patients 45 years. No significant differences emerged for maternal chronic diseases (hypertension, diabetes), for gestational diabetes, obstetric complications (oligohydramnios, IUGR, placental disorders) and instrumental delivery. Conclusions. The pregnancy in age 40 is associated with an increased risk for the majority of the maternal-fetal complications, but it is mostly over 45 years that the increase of frequency of gestational diseases involving the cardiovascular system becomes highly prevalent (gestational hypertension and preeclampsia); fetal complications such as low birth weight and prematurity are increased. Our study suggests that becoming pregnant at extremely advanced reproductive age ( 45years) exposes the woman to hypertensive complications such as gestational hypertension and preeclampsia. During the last decades, in industrialized countries, women are voluntarily postponing pregnancy for economic, professional, social and personal reasons. In 2011 in Italy the average age for pregnancy was 31.4 years at time of delivery. This is approximately 1.5 years more than in 2008 (29.8) and in mothers of Italian citizenship the average age of delivery is 32 years. Nearly 7% of children born had a mother at least 40 years of age, more than in 2008 (5.7% of children). At the same time, a reduction in births to mothers less than 25 years old was observed: 10.9 % in 2011 compared with 11.1% in 2008 (1). This tendency has created a social phenomenon characterized by an increase in women of advanced age desiring to obtain a pregnancy (2). Many studies have demonstrated that advanced maternal age has an impact not only on ability to conceive, but also on pregnancy and maternal-fetal health in the following ways: - an increase in chronic and gestational maternal illnesses such as hypertension/preeclampsia and diabetes mellitus (3, 4); - an increase in fetal complications such as chro- PNI -distacco intempestivo di placenta normoinserita) e di parti vaginali operativi. Considerando solo il gruppo over 40, dal confronto fra il gruppo A (40-44 anni) e il gruppo B ( 45 anni) è emerso come nelle over 45 vi sia una frequenza significativamente aumentata di preeclampsia (1,5% vs 13,2%), ipertensione gestazionale (5,8% vs 28,9%), ricorso al taglio cesareo (67,2% vs 92,1%), basso peso alla nascita (15% vs 34,2%), prematurità (19,3% vs 31,6%) e Apgar inferiore a 7 al primo minuto (5,8% vs 18,4%). Nessuna differenza significativa è emersa per le patologie materne croniche (ipertensione, diabete) né per diabete gestazionale, complicanze ostetriche (oligoamnios, IUGR, anomalie placentari) e parti vaginali operativi. Conclusioni. La gravidanza in età 40 anni comporta un aumento di rischio per la maggior parte delle complicanze materno-fetali, ma è soprattutto sopra i 45 anni che l aumento di frequenza di alcune patologie gestazionali che coinvolgono il sistema cardiovascolare diventa fortemente prevalente (ipertensione gestazionale e preeclampsia); ad esse si associano complicanze fetali quali il basso peso alla nascita e la prematurità. Il nostro studio suggerisce come una gravidanza insorta in età riproduttiva estrema ( 45anni) esponga la donna soprattutto a complicanze ipertensive quali ipertensione gestazionale e preeclampsia. KEY WORDS: Very advanced maternal age - Maternal complications - Neonatal complications. Età materna molto avanzata - Complicanze materne - Complicanze neonatali. mosomal abnormalities and malformations (5), IUGR and intra-uterine death (6-8); - an increase in complications during birth which leads to an increase in C-sections and instrumental delivery (3, 4, 9, 10); - an increase in neonatal complications such as premature birth, low birth weight, IUGR and macrosomia (3, 4, 7); - an increase in maternal post-partum complications such as hemorrhage (4, 11). Some questions are still left to be addressed. While during the Sixties the pregestational health condition was an important risk factor for complications in pregnancy, in later years women s health has improved in industrialized countries and it is therefore important to consider other risk factors and clinical aspects which could affect pregnancy outcome in advanced maternal age. Finally it is still an open debate about what the age limit is which puts a woman at greater risk for the development of pregnancy complications: it is not yet clear whether there is in late reproductive years, before menopause (> 45 years old), a risk profile more specific than that detected beyond the generic limit of 40 years old and what is the most appropriate surveillance in pregnancy. The aim of our study is to evaluate the pregnancy 741

complications, mode of delivery and neonatal outcome in women of advanced reproductive age (> 40 years) and very advanced reproductive age (> 45 years) compared to younger women (25-35 years). Materials and methods In our retrospective observational study of a total of 3650 women who gave birth at the Department of Gynaecologic-Obstetric Sciences and Urologic Sciences, from January 2010 to December 2011 (hospitalized at the Department of Obstetrics and transferred to room delivery room) there were 343 (9.3%) patients aged > 40 years identified. We selected a sample as a control group of 527 women aged between 25 and 35 years hospitalized to give birth during the same period. From selected groups we excluded twin pregnancies and pregnancies resulting in intrauterine death. The final sample is thus represented by a study group consisting of 312 women aged > 40 years, and by a control group of 510 women aged between 25 and 35 years. The study group was further divided according to age into two subgroups: - 274 (87.8%) aged between 40 and 44 years (group A); - 38 (12.2%) aged > 45 years (group B). The following data were analyzed: - Body Mass Index (BMI: kg/m²); - obstetric anamnesis (parity and previous deliveries); - assisted vs spontaneous conception; - gestational morbidity: chronic maternal diseases (diabetes mellitus, chronic hypertension) gestational maternal diseases (gestational diabetes, gestational hypertension, preeclampsia) and obstetric complications (IUGR, placental disorders, oligohydramnios); - type of delivery (cesarean section, spontaneous delivery, instrumental delivery) and gestational age at delivery; - neonatal outcome (birth weight, Apgar score in first minute); - days of hospital stay. The statistics were analyzed using SPSS 16.0 for Windows. Comparisons between the groups were performed with ANOVA and χ². The significance was considered for values of p< 0.05. M.G. De Stefano et al. Results The mean age was 41.4 ± 1.2 years in group A, 46.5 ± 1.9 in group B and 29.8 ± 3.2 in control group. The mean BMI of patients was 27.5 ± 3.8 in group A, 27.8 ± 5.2 in group B and 26.5 ± 4 in control group. With regards to obstetric anamnesis the percentage of nulliparity was greater in control group in comparison with study group (38.1% vs 53.7%, p < 0.001) with a decrease in previous C-sections (15.7% vs 32,7%, p<0.001). However, taking into consideration only those women above age 40, in group A (40-44 years) the percentage of nulliparity is less with respect to group B (> 45 years) (33.9% vs 68.4%, p<0.001). The need for assisted reproduction was significantly higher in women over 40 with respect to those between 25 and 35 years (9.3% vs 0.2% p<0.001) and in particular in group B over 45 years (50% of women over 45 used assisted reproduction). The morbidity during pregnancy (chronic maternal diseases, gestational maternal diseases and obstretric complications), delivery outcome (type of delivery, gestational age at delivery), neonatal outcome (birth weight and neonatal Apgar score) and hospitalization stay are showed in Table 1 and Table 2. An increased frequency of chronic maternal diseases (chronic hypertension and diabetes mellitus) in the study group compared to control group was noted (respectively 6.1% vs 2%, p<0.005 and 2.6% vs 0.4% p<0.05). Gestational maternal diseases and obstetric complications were also more frequent in the group > 40 years with respect to control group: gestational diabetes 9% vs 2.5% (p<0.001), oligohydramnios 7.4% vs 3.7 (p< 0.05), IUGR 6.7% vs 2.5% (p< 0.005). No significant differences were noted for preeclampsia (2.9% vs 1.2%) and placental disorders (4.8% vs 2.4% ) (Table 1). Over 45 years (group B) greater differences were noted compared with women between 40 and 44 years (group A) in terms of gestational hypertension (28.9% vs 5.8% p<0.001) and preeclampsia (13.2% vs 1.5% p< 0.001) (Table 2). Regarding delivery, we highlighted in the age group > 40 years compared to the control group an increase of the number of cesarean section (70.2% vs 48.2%, p <0.001), an increase in the frequency of preterm delivery between 37 and 34 weeks (16% vs 742

Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks 6.7%, p <0.001) and very preterm delivery < 34 weeks (4.8% vs 6.7%, p <0.001) and a reduction in average gestational age at delivery (38.1 weeks vs 38.7 weeks, p <0.05) (Table 1). Analyzing group A (40-44 years) compared to group B (> 45 years) (Table 2) confirmed a significant increase in the use of cesarean section (67.2% vs 92.1%, p <0.005), an increase in the frequency of preterm delivery between 37 and 34 weeks (15.3% vs 21.1%, p <0.05) and very preterm delivery < 34 weeks (4% vs 10.5%, p <0, 05) and a reduction in average gestational age at delivery (38.3 weeks vs 37.1 weeks, p <0.001). The C-sections most frequently performed in patients of group B (> 45 years) compared with group A (40-44 years) had the following indications: - gestational hypertension (23.4% vs 9.5%, p<0.05); - preeclampsia (12.8% vs 3.5%, p<0.05); - maternal request (27.7% vs 7.5%, p<0.001). In addition, considering neonatal outcome, several important differences were noted among groups. In the study groups > 40 years compared with control group (Table 1) there was: - a reduction in average birth weight (3060.2 grams vs 3115.4 grams, p<0.05); - an increase in the percentage of birth weight TABLE 1-FREQUENCY OF CHRONIC MATERNAL DISEASES, COMPLICATIONS IN PREGNANCY, TYPE OF DELI- VERY, COMPLICATIONS OF CHILDBIRTH AND DAYS OF HOSPITALIZATION IN WOMEN AGED 40 AND IN CONTROLS. Characteristics > 40 years (n = 312) 25-35 years (n = 510) p Chronic hypertension % (n) 6,1 (19) 2 (10) <0,005 Diabetes mellitus pregestational % (n) 2,6 (8) 0,4 (2) <0,05 Gestational hypertension % (n) 8,7 (27) 2 (10) <0,001 Preeclampsia % (n) 2,9 (9) 1,2 (6) ns Gestational diabetes % (n) 9 (28) 2,5 (13) <0,001 Placental disorder % (n) 4,8 (15) 2,4 (12) ns Oligohydramnios % (n) 7,4 (23) 3,7 (19) <0,05 IUGR % (n) 6,7 (21) 2,5 (13) <0,005 Cesarean delivery % (n) 70,2 (219) 48,2 (246) <0,001 Spontaneous delivery % (n) 27,6 (86) 50,8 (259) <0,001 Instrumental delivery % (n) 2,2 (7) 0,8 (4) ns Gestational age at delivery (weeks), mean ± SD 38,1±2,05 38,7±1,56 <0,05 Prematurity (< 37 weeks) % (n) 20,8 (65) 7,5 (38) <0,001 Birth weight (grams), mean ± SD 3060,2±607,5 3155,3±528,5 <0,05 Birth weight < 2500 grams % (n) 17,3 (54) 10,6 (54) <0,001 Apgar score <7 in the first minute % (n) 7,4 (23) 1,6 (8) <0,001 Days of hospitalization, mean ± SD 5,6±2,6 4,6+0,9 <0,05 743

< 2500 grams (17.3% vs 10.6%, p<0.001); - an increase in the percentage of Apgar scores < 7 in the first minute (7.4% vs 1.6%, p< 0,001). These differences are very evident from the comparison between group A and group B (Table 2): - a reduction in average birth weight (3089.3 grams vs 2850.1 grams, p <0.05); - an increase in the percentage of birth weight <2500 grams (15% vs 34.2%, p <0.001); - an increase in the percentage of Apgar score < 7 in the first minute (5.8% vs 18.4%, p: 0.005). Finally, hospitalization is longer in the study group compared with the control group (5.6 days vs 4.6 days p<0.05) particularly of note 5.5 days for M.G. De Stefano et al. TABLE 2 - FREQUENCY OF CHRONIC MATERNAL DISEASES, COMPLICATIONS IN PREGNANCY, TYPE OF DELIVERY, COMPLICATIONS OF CHILDBIRTH AND DAYS OF HOSPITALIZATION IN WOMEN AGED 40-44 (GROUP A) AND > 45 YEARS (GROUP B). Characteristics 40-44 years (n = 274) > 45 years (n = 38) p Chronic hypertension % (n) 5,8 (16) 7,9 (3) ns Diabetes mellitus pregestational % (n) 2,2 (6) 5,3 (2) ns Gestational hypertension % (n) 5,8 (16) 28,9 (11) <0,001 Preeclampsia % (n) 1,5 (4) 13,2 (5) <0,001 Gestational diabetes % (n) 8,8 (24) 10,5 (4) ns Placental disorders % (n) 4,4 (12) 7,9 (3) ns Oligohydramnios % (n) 6,9 (19) 10,5 (4) ns IUGR % (n) 6,2 (17) 10,5 (4) ns Cesarean delivery % (n) 67,2 (184) 92,1 (35) <0,005 Spontaneous delivery % (n) 30,7 (84) 5,3 (2) <0,005 Instrumental delivery % (n) 2,2 (6) 2,6 (1) ns Gestational age at delivery (weeks), mean ± SD 38,3±1,98 37,1±2,18 <0,001 Prematurity (< 37 weeks) % (n) 19,3 (53) 31,6 (12) <0,05 Birth weight (grams), mean ± SD 3089,3±587,9 2851,1±707,7 <0,05 Birth weight < 2500 grams % (n) 15 (41) 34,2 (13) <0,001 Apgar score < 7 in the first minute % (n) 5,8 (16) 18,4 (7) <0,01 Days of hospitalization, mean ± SD 5,5+2,5 6,3+3,3 <0,05 women between 40 and 44 (group A) and 6.3 days in women > 45 years (group B). Discussions and conclusions Between January 2010 and December 2011, in our department, births by women > 40 years of age were 9.3% of total births (343 out of 3650), within the Italian statistical average (1). Notwithstanding the progressive increase of advanced maternal age births and an improvement in women s health in developed nations, maternal and fetal complications in the decade preceding menopause 744

Pregnancy in advanced ( 40) and very advanced ( 45) reproductive age: maternal and fetal risks (between 40 and 50 years) seem greater when compared with pregnancies under 40 years of age. In fact, from this study emerges the frequency with which women beyond 40 years of age display chronic maternal diseases (chronic hypertension, diabetes mellitus) and gestational maternal diseases/ obstetric complications (gestational hypertension, gestational diabetes, oligohydramnios, IUGR). In 70% of the cases a C-section is performed and preterm and very preterm delivery are observed. Newborn with low birth weight and with Apgar score < 7 at 1 minute are observed. Hospital stays are longer with higher frequency of pre and post-partum complications. These conditions become more relevant when analyzing women over 45 particularly with regard to gestational hypertension (28.9%) and preeclampsia (13.2%). The causes of the relationship between advanced maternal age and gestational hypertension and preeclampsia are to be examined in the placental uterine vascular system. Sclerotic arterial uterine lesions increase with age from 11% between 17 and 29 years 61% between 30 and 39 years and 83% over 39 years. This vascular failure is responsible for the uterus being unable to adapt to the increased hemodynamic requests during a pregnancy (12). These studies further confirm the American Heart Association s claim that pregnancy is a stress test to the cardiovascular system and, in particular, for women who develop preeclampsia, a failed stress test which unmasking early or preexisting endothelial dysfunction and vascular disease (13). It remains unclear, however, whether assisted reproduction technologies over age 45 (50% of women > 45) are responsible for such illnesses or whether they are due to age. As well evidenced in certain studies (3, 14-16) assisted methods of reproduction have an impact on maternal diseases like preeclampsia. Also in the women > 45 years is very high the C- section rate (92%), especially elective C-section, the frequency of preterm delivery (21.1%) and very preterm delivery (10.5%), of infants with low birthweight (34.2%) and Apgar score <7 in the first minute (18.4%). One in three women opted for a C-section and a motivating factor is assisted methods of conception making the pregnancy precious (3). A second motivating factor for C-sections is due to a greater cultural conditioning in women of advanced reproductive age who perceive a greater risk to themselves and the fetus compared with younger women (17). We must bear in mind the debate on C-sections without medical indications is still very vibrant (18-23). There is no evidence that a C-section performed without medical cause is any safer for the mother s health or the newborn s health with respect to a vaginal birth. In light of these results, women over 45 should be considered most at risk for particular pregnancy complications (gestational hypertension, preeclampsia, preterm delivery, low birth weight). For this reason it is necessary to have detailed counseling on the maternal and fetal risks, a close monitoring of the pregnancy, and prenatal and obstetric assistance, targeted to the prevention of these complications. One limitation of our study is the sample size of women > 45 years, which represents the true advanced reproductive age and deserves further evaluation in multicenter studies. Finally, it remains an open question: Why fetal and maternal outcomes are unfavorable in spite of the good health and economic conditions typical of these patients of advanced reproductive age?. The impact of better economic conditions, social and health in older age group it is still not clear why it should set up a potentially preventive role of risk, but the advanced maternal age per sé is a real independent risk factor for the majority of maternal complications discussed above but especially for gestational hypertension and preeclampsia. It would be a long-term post pregnancy follow-up of these patients to assess the impact of pregnancy in advanced reproductive age on cardiovascular risk in menopause. 745

References 1. Istat, Natalità e fecondità della popolazione residente, 14 Novembre 2012. 2. Ruman J, Klein J, Sauer MV. Understanding the effects of age on female infertility. Minerva Ginecol 2003;55:117-27. 3. Schoen C, Rosen T. Maternal and perinatal risks for women over 44 A review. Maturitas 2009;64:109-113. 4. Yogev Y, Melamed N, Tenembaum-Gavish K, et al. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol 2010;203:558.e1-7. 5. Hollier LM, Leveno KJ, Kelly MA, et al. Maternal age and malformations in singleton births. Obstet Gynecol 2000;96:701-6. 6. Hoffman M C, Jeffers S, Carter J, et al. Pregnancy at or beyond age 40 years is associated with an increased risk of fetal death and other adverse outcomes. Am J Obstet Gynecol 2007; 196:e11-13. 7. Carolan M, Frankowska D. Advanced maternal age and adverse perinatal outcome: A review of the evidence. Midwifery 2011;27:793-801. 8. Nelson SM, Telfer EE, Anderson RA. The ageing ovary and uterus: new biological insights. Human Reproduction Update 2013;19:67-83. 9. Smith GC, Cordeaux Y, White IR, et al. The effect of delaying childbirth on primary cesarean section rates. PLoS Med 2008;5:e144. 10. Takahashi H, Watanabe N, Sugibayashi R, et al. Increased rate of cesarean section in primiparous woman aged 40 years old or more: a single-center study in Japan. Arch Gynecol Obstet 2012;285:937-941. 11. Jaleel R, Khan A. Post-partum haemorrhage-a risk factor analysis. Mymensingh Med J 2010;19(2):282-9. 12. Naeye RL. Maternal age, obstetric complications, and the out- M.G. De Stefano et al. come of pregnancy. Obstest Gynecol 1983;61:210-6. 13. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness- Based Guidelines for Prevention of Cardiovascolar Disease in Women, 2011 Update: A guideline From The American Heart Association. Circulation 2011;123:1243-1262. 14. Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005; 106:1039-1045. 15. Woldringh GH, Frunt MHA, Kremer JAM, Spaanderman MEA. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Human Reproduction 2006;21(11): 2948-2954. 16. Paulson R J, Boostanfar R, Saadat P, et al. Pregnancy in the sixth decade of life. Obstetric outcomes in women of advanced reproductive age. JAMA 2002;288:2320-23. 17. Bayrampour H, Heaman M, et al. Comparison of perception of pregnancy risk of nulliparous women of advanced maternal age and younger age. J Midwifery Womens Health 2012; 57:445-453. 18. Minkoff H, et al. Ethical dimensions of elective primary cesarean section. Obstet. Gynecol 2004;103:387-392. 19. Hale RW, Harer WB. Elective prophylactic cesarean delivery. ACOG clinical review 2005;10:1-15. 20. D Alton M, et al. National institutes of health: state of the science conference statement. Cesarean delivery on maternal request. Obstet Gynecol 2006;1007, 1386. 21. Plante LA. Public Healt implications of cesarean on demand. Ostet Gynecol Survey 2006;61:807-15. 22. Scott JR. Cesarean delivery on request. Obstet Gynecol 2006;107:1222-1223. 23. Larson SL. Public health implications of cesarean on demand. Obstet gynecol Survey 2007;62:323-325. 746